Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII. Recio-López P, Valladolid-Acebes I, Hadwiger P, Hossbach M, Krampert M, Prata C, Berggren PO, & Juntti-Berggren L. BioFactors (Oxford, England), 2022, Online ahead of print. Read Article.